Back to Search
Start Over
End of an era for erythropoiesis‐stimulating agents in oncology
- Source :
- International Journal of Cancer. 146:2829-2835
- Publication Year :
- 2020
- Publisher :
- Wiley, 2020.
-
Abstract
- Erythropoiesis-stimulating agents (ESAs) are available to treat chemotherapy-induced anemia (CIA). In 2007-2008, regulatory notifications advised of venous thromboembolism and mortality risks while the Center for Medicare and Medicaid Services' restricted ESA initiation to patients with hemoglobin
- Subjects :
- Adult
Male
Cancer Research
medicine.medical_specialty
Anemia
medicine.medical_treatment
Antineoplastic Agents
Medical Oncology
03 medical and health sciences
Patient safety
0302 clinical medicine
Breast cancer
hemic and lymphatic diseases
Internal medicine
Humans
Medicine
Dosing
Practice Patterns, Physicians'
Adverse effect
Reimbursement
Chemotherapy
business.industry
medicine.disease
United States
Oncology
030220 oncology & carcinogenesis
Hematinics
Female
business
Medicaid
Subjects
Details
- ISSN :
- 10970215 and 00207136
- Volume :
- 146
- Database :
- OpenAIRE
- Journal :
- International Journal of Cancer
- Accession number :
- edsair.doi.dedup.....9b16c80598f233cab573dcabed1e7160
- Full Text :
- https://doi.org/10.1002/ijc.32917